BIOMAT Database Logo BIOMAT Database Logo

Immunosuppressive treatment in lower motor neuron syndrome with autoantibodies against GM1 ganglioside. 1993

C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
Neurological Institute, Veterans General Hospital, Taipei, Taiwan.

We report the results of immunosuppressive treatment with intravenous cyclophosphamide in 12 patients with lower motor neuron syndrome and elevated titers of serum autoantibodies to GM1 ganglioside. All patients had lower motor neuron dysfunction including proximal or distal weakness, fasciculation and muscle atrophy, but no upper motor neuron dysfunction such as hyperreflexia, spasticity or Babinski's sign. Electrophysiological studies revealed no evidence of conduction block, but EMG findings of acute or chronic denervation in the limbs were present. Serum biochemistry and immunological studies were negative for M protein. After a 6-month follow-up, despite a fall in antibody titer, there was no significant clinical improvement in any of the patients.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009046 Motor Neurons Neurons which activate MUSCLE CELLS. Neurons, Motor,Alpha Motorneurons,Motoneurons,Motor Neurons, Alpha,Neurons, Alpha Motor,Alpha Motor Neuron,Alpha Motor Neurons,Alpha Motorneuron,Motoneuron,Motor Neuron,Motor Neuron, Alpha,Motorneuron, Alpha,Motorneurons, Alpha,Neuron, Alpha Motor,Neuron, Motor
D009133 Muscular Atrophy Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation. Atrophy, Muscle,Neurogenic Muscular Atrophy,Neurotrophic Muscular Atrophy,Atrophies, Muscle,Atrophies, Muscular,Atrophies, Neurogenic Muscular,Atrophies, Neurotrophic Muscular,Atrophy, Muscular,Atrophy, Neurogenic Muscular,Atrophy, Neurotrophic Muscular,Muscle Atrophies,Muscle Atrophy,Muscular Atrophies,Muscular Atrophies, Neurogenic,Muscular Atrophies, Neurotrophic,Muscular Atrophy, Neurogenic,Muscular Atrophy, Neurotrophic,Neurogenic Muscular Atrophies,Neurotrophic Muscular Atrophies
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D005260 Female Females
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl

Related Publications

C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
Autoantibodies to GM1 ganglioside: different reactivity to GM1-liposomes in amyotrophic lateral sclerosis and lower motor neuron disorders.
August 1991, Journal of the neurological sciences,
C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
January 2004, European journal of neurology,
C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
Lower motor neuron syndrome associated with anti-GM1 antibodies.
January 1997, Medicina,
C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
[Lower motor neuron disease (syndrome) associated with anti GM1 antibodies].
January 1999, Ryoikibetsu shokogun shirizu,
C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited.
July 2014, Journal of neuroimmunology,
C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
[Proximal lower motor neuron syndrome associated with serum antibodies to asialo-GM1, GM1 and LM1].
August 1993, Rinsho shinkeigaku = Clinical neurology,
C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
Motor conduction block and high titres of anti-GM1 ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome.
September 1993, Journal of neurology, neurosurgery, and psychiatry,
C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
Neonatal lower motor neuron syndrome associated with maternal neuropathy with anti-GM1 IgG.
July 2004, Neurology,
C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
[Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
October 1992, Rinsho shinkeigaku = Clinical neurology,
C P Tsai, and K P Lin, and K K Liao, and S J Wang, and V Wang, and K P Kao, and Z A Wu
Peripheral nervous system and central nervous system pathology in rapidly progressive lower motor neuron syndrome with immunoglobulin M anti-GM1 ganglioside antibody.
June 2004, Journal of the peripheral nervous system : JPNS,
Copied contents to your clipboard!